Historical Valuation
BJ ENT WATER (00371) is now in the Fair zone, suggesting that its current forward PE ratio of 14.54 is considered Fairly compared with the five-year average of 9.24. The fair price of BJ ENT WATER (00371) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：2.56
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
BJ ENT WATER (00371) has a current Price-to-Book (P/B) ratio of 0.80. Compared to its 3-year average P/B ratio of 0.72 , the current P/B ratio is approximately 11.95% higher. Relative to its 5-year average P/B ratio of 0.73, the current P/B ratio is about 10.75% higher. BJ ENT WATER (00371) has a Forward Free Cash Flow (FCF) yield of approximately 13.76%. Compared to its 3-year average FCF yield of 8.14%, the current FCF yield is approximately 69.02% lower. Relative to its 5-year average FCF yield of 2.77% , the current FCF yield is about 397.33% lower.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of 00371 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 00371 in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is 00371 currently overvalued or undervalued?
BJ ENT WATER (00371) is now in the Fair zone, suggesting that its current forward PE ratio of 14.54 is considered Fairly compared with the five-year average of 9.24. The fair price of BJ ENT WATER (00371) is between to according to relative valuation methord.
What is BJ ENT WATER (00371) fair value?
00371's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of BJ ENT WATER (00371) is between to according to relative valuation methord.
How does 00371's valuation metrics compare to the industry average?
The average P/S ratio for 00371's competitors is , providing a benchmark for relative valuation. BJ ENT WATER Corp (00371) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for BJ ENT WATER (00371) as of Jan 16 2026?
As of Jan 16 2026, BJ ENT WATER (00371) has a P/B ratio of 0.80. This indicates that the market values 00371 at 0.80 times its book value.
What is the current FCF Yield for BJ ENT WATER (00371) as of Jan 16 2026?
As of Jan 16 2026, BJ ENT WATER (00371) has a FCF Yield of 13.76%. This means that for every dollar of BJ ENT WATER’s market capitalization, the company generates 13.76 cents in free cash flow.
What is the current Forward P/E ratio for BJ ENT WATER (00371) as of Jan 16 2026?
As of Jan 16 2026, BJ ENT WATER (00371) has a Forward P/E ratio of 14.54. This means the market is willing to pay $14.54 for every dollar of BJ ENT WATER’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for BJ ENT WATER (00371) as of Jan 16 2026?
As of Jan 16 2026, BJ ENT WATER (00371) has a Forward P/S ratio of 0.97. This means the market is valuing 00371 at $0.97 for every dollar of expected revenue over the next 12 months.